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OVER THE COUNTER PLAN B AND DECISIONAL AUTONOMY FOR ADOLESCENTS  
Jared Pickell 
 
 
 
 
 
INTRODUCTION 
College students at Shippensburg University can get Plan B emergency contraception 
from a vending machine for $25.
1
  New York City public schools distributed free Plan B to 567 
high school students, without parental consent, during the 2011-2012 school year.
2
  About one 
out of five pharmacies illegally denies emergency contraception to seventeen-year-old girls.
3
  An 
Indiana United States Senate candidate recently said he opposed abortion and emergency 
contraception “even when life begins in that horrible situation of rape, that it is something God 
intended to happen.”4  Wheaton College, an evangelical Christian liberal arts school in Illinois, 
requested an injunction against Obamacare’s emergency contraception insurance coverage, only 
to find out that the school itself had been inadvertently covering Plan B long before Obamacare 
went into effect.
5
  
                                                        
1 Associated Press, Morning-After Pills in Vending Machine, POLITICO, Feb. 7, 2012, 
http://www.politico.com/news/stories/0212/72592.html. 
2 Ahemona Hartocollis, More Access to Contraceptives in City Schools, N.Y. TIMES, Sep. 23, 2012, 
http://www.nytimes.com/2012/09/24/nyregion/resistance-low-to-school-contraceptives-effort-new-york-health-
officials-say.html.  This was part of a pilot program for increasing the use and availability of contraceptives for high 
risk students who may not have easy access to healthcare regarding these matters.  While parental consent is not 
necessary, the program does have a parental “opt out” feature.  Only 1-2 % of parents chose to opt out. 
3 Maia Szalavitz, Plan B: 1 in 5 Pharmacists May Deny Eligible Teens Access to Emergency Contraception, TIME, 
Mar. 26, 2012, http://healthland.time.com/2012/03/26/plan-b-1-in-5-pharmacists-may-deny-eligible-teens-access-to-
emergency-contraception/. 
4 Louise Radnofsky, Indiana GOP Candidate Sparks New Fight Over Abortion, WALL ST. J., Oct. 24, 2012, 
http://online.wsj.com/article/SB10001424052970203937004578077122446378616.html  (the candidate is Richard 
Mourdock). 
5 Laura Bassett, Wheaton College “Inadvertently” Covered Emergency Contraception Before Birth Control 
Mandate, HUFFINGTON POST, Aug. 2, 2012, http://www.huffingtonpost.com/2012/08/02/wheaton-college-birth-
control_n_1734919.html. 
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The heavily politicized stories above help frame the debate over whether emergency 
contraception, namely, Plan B,
6
 should be available over the counter (OTC) to young women 
under the age of seventeen.  This debate seems to be largely political, and it incites strong, 
sometimes visceral, reactions.  There is no shortage of literature scolding the FDA and the 
Department of Health and Human Services
7
 and their officers for allowing political, and perhaps 
religious, inclinations to “win the day” in place of scientific and medical research.  Scholars have 
also written extensively on First Amendment privacy issues and procreation decisions as a 
fundamental right, and how the legacy of Griswold,
8
 Roe,
9
 and Casey
10
 “obviously” mandates 
that all women should have access to OTC emergency contraception.  The political bickering and 
the circularity of constitutional jurisprudence concerning Plan B and similar procreation issues 
obfuscates the importance of decisional autonomy for individuals, their medical care, and their 
bodily integrity.   
This article checks the messy politics and the nebulous constitutional debates at the door 
and focuses on the decisional capacity of adolescent women to decide for themselves whether to 
use OTC Plan B.  From the principle of individual autonomy, especially when it comes to 
making medical decisions, this article’s central thesis is that most adolescent women possess the 
cognitive and decision-making skills necessary to decide whether to use contraception, 
specifically, Plan B, free from red tape.  This piece will use various law review articles, articles 
from medical, sociological, and psychological journals, as well as caselaw and examples by way 
                                                        
6 Plan B is “a backup plan that helps prevent pregnancy after unprotected sex or birth control failure.” PLAN B ONE-
STEP, “What Plan B One-Step Is,” available at http://www.planbonestep.com/what-is-plan-b.aspx. 
7  See infra, Part I. 
8 Griswold v. Connecticut, 381 U.S. 479 (1966) (holding that the Constitution contains a right to privacy, and that 
the Connecticut law banning contraceptives violated this right and was therefore unconstitutional). 
9 Roe v. Wade, 410 U.S. 113 (1973) (holding that the right to privacy found in the Due Process Clause of the 
Fourteenth Amendment extended to a woman’s decision to have an abortion, balanced by the state’s interest in both 
protecting the fetus and protecting the woman’s health). 
10 Planned Parenthood of Southeastern Pennsylvania v. Casey, 505 U.S. 833 (1992) (affirmed a woman’s right to 
have an abortion). 
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of comparison.  From these sources, this piece argues that Plan B, approved for OTC use by 
seventeen-year-old women, should also be approved for OTC use by all adolescent women of 
reproductive age who possess the cognitive ability to make the autonomous decision to take Plan 
B. 
Part I will provide background to the development of the OTC status of Plan B, its 
efficacy as a method of contraception, and the consensus of the medical community as to its 
safety, while emphasizing Plan B as a method of contraception and not an abortifacient.
11
  Part II 
will set up the article’s general framework and approach—the value of individual autonomy in 
making medical decisions—and highlight literature exploring adolescents’ cognitive and 
emotional ability to make medical decisions, and other important decisions, generally.  Part III 
will apply the framework of Part II to the debate over OTC Plan B for adolescent women.  
Part IV will offer a solution to the debate regarding OTC Plan B for adolescent women—
these women should decide whether to take Plan B for themselves because their decision-making 
faculties and the literature on Plan B’s safety dictate that their decisional autonomy should be 
respected above all other considerations.  It will highlight similar age-based regulations and 
restrictions (or lack thereof), and examine their justifications, offering a pause point for 
comparison with the OTC Plan B issue.  These comparative examples include various types of 
tobacco regulation, and laws presuming that minors lack the capacity to make contracts.  Part IV 
will also use its conclusions regarding the Plan B debate to offer broader instruction—in our 
policy-making and legislation we must defer more to the medical community and to the 
decisional autonomy of the individual to make medical decisions.  And for medication and 
treatment approved for OTC use, this decisional autonomy should always extend to adolescents. 
                                                        
11 Plan B “should not affect or terminate an existing pregnancy.” PLAN B ONE-STEP, “What Plan B One-Step Is,” 
available at http://www.planbonestep.com/what-is-plan-b.aspx. 
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I. HISTORY OF THE DEVELOPMENT OF PLAN B AND ITS OTC STATUS 
 
In 1999, the Food and Drug Administration (FDA) approved the use of the synthetic 
hormone levonorgestrel
12
 as a prescription-only emergency contraceptive that would be sold as 
Plan B.
13
  Plan B originally consisted of two tablets—the first pill should be ingested within 
seventy-two hours of unprotected sex, and the second pill twelve hours later.
14
  If taken properly, 
Plan B can prevent approximately 89 percent of unwanted pregnancies.
15
  It is important to 
remember that Plan B is not an abortion pill;
16
 Plan B works to prevent fertilization,
17
 or if 
fertilization does occur, to prevent implantation.
18
  When taken as directed, Plan B is safe
19
 and 
its “side effects are generally mild,” with some women experiencing “side effects similar to 
many birth control pills.”20  These side effects include heavier or lighter periods, nausea, lower 
abdominal pain, fatigue, headaches, dizziness, and breast tenderness.
21
 
Soon after, the lack of practicality of getting a prescription filled for a treatment that is 
only viable for less than seventy-two hours after unprotected sex became apparent.
22
  The fact 
that unprotected sex can often be a traumatic experience complicates the matter further.
23
  Due to 
the exigency of taking Plan B within seventy-two hours after unprotected sex, and the difficulties 
                                                        
12 Levonorgestrel is “a synthetic progestogen (any progestational steroid, such as progesterone) that is used as a 
form of contraception in women.”  ENCYCLOPEDIA BRITANNICA, “Levonorgestrel,” available at 
http://www.britannica.com/EBchecked/topic/338040/levonorgestrel. 
13 Barbara Chevalier, The Constitutionality of the FDA’s Age-Based Plan B Regulations: Why the FDA Made the 
Wrong Decision, 22 WIS. WOMEN’S L.J. 235, 238 (2007). 
14 Id. at 239. 
15 Sydney Kokjohn, The Imposition of an Age Restriction on Over-the-Counter Access to Plan B Emergency 
Contraception: Violating Constitutional Rights to Privacy and Exceeding Statutory Authority, 9 MINN. J.L. SCI. & 
TECH. 369, 372 (2008). 
16 There is an abortion pill, mifepristone, commonly known as RU-486.  It has been available by prescription in the 
United States, but it is different from Plan B.  Chevalier, supra note 13, at 240. 
17 Fertilization is the union of sperm and egg. 
18 Implantation is when the fertilized egg, or embryo, attaches to the uterus. 
19 The FDA’s Center for Drug Evaluation and Research (CDER) ensures that drugs, before their approval for the 
market, “work correctly and that their health benefits outweigh their known risks.”  FDA, “Development & 
Approval Process (Drugs),” available at http://www.fda.gov/drugs/developmentapprovalprocess/default.htm. 
20 PLAN B ONE-STEP, “FAQs,” available at http://www.planbonestep.com/plan-b-faq.aspx. 
21 Id. 
22 Kokjohn, supra note 15, at 374. 
23 Id. 
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of getting a prescription filled under those circumstances, Plan B’s manufacturer filed an OTC 
petition with the FDA in 2003.
24
  This type of petition is known as an “over-the-counter switch” 
and is the method through which the FDA allows drugs to be sold without a prescription.
25
  Plan 
B’s manufacturer revised its petition in 2004 after the FDA told it that there was not enough data 
to prove that adolescents fifteen and younger could use Plan B safely without a doctor’s 
oversight.
26
  This revised petition requested that only women age sixteen and older have access 
to OTC Plan B.
27
  After numerous delays by the FDA,
28
 and serious political involvement,
29
 on 
August 23, 2006 the FDA approved OTC use of Plan B, but only for women over the age of 
eighteen.
30
  To enforce the ban on the sale of OTC Plan B for adolescents under eighteen, the 
FDA required that only pharmacies or other facilities with a healthcare professional sell Plan B.
31
  
The FDA also required that Plan B be kept behind the counter, and that women seeking to 
purchase it present proof of age.
32
 
In 2009, the FDA approved the sale of Plan B One-Step,
33
 a one-pill version of the 
emergency contraception, to seventeen-year-olds without a prescription.
34
  But this was only 
                                                        
24 Rob Stein, Obama Administration Refuses to Relax Plan B Restrictions, WASH. POST, Dec. 7, 2011, 
http://www.washingtonpost.com/national/health-science/obama-administration-refuses-to-relax-plan-b-
restrictions/2011/12/07/gIQAF5HicO_story.html. 
25 21 C.F.R. § 310.200(b).  Before an OTC switch takes place, the drug must meet certain FDA criteria.  These 
include: (1) an acceptable safety profile based on prescription use and experience; (2) a low potential for abuse; (3) 
an appropriate safety and therapeutic index; (4) a positive benefit-to-risk assessment; and (5) it is needed for a 
condition that is self-recognizable, self-limiting, and requires minimal intervention by a healthcare practitioner for 
treatment.  Id. 
26 Kokjohn, supra note 15, at 375. 
27 Id. at 376. 
28 For example, the FDA missed its statutory deadline for ruling on the application.  Id. 
29 For example, then Senator Hillary Rodham Clinton promised to “prevent the Senate from voting on Lester 
Crawford’s nomination to be the new Commissioner of the FDA until the agency ruled on Plan B’s pending 
application.”  Id.  
30 Id. at 377. 
31 Id.  
32 Id. 
33 The FDA approved the safety and use of Plan B One-Step on July 13, 2009.  See Drug Information Online, FDA 
Approves Plan B One-Step, July 13, 2009, available at http://www.drugs.com/newdrugs/fda-approves-plan-b-one-
step-new-one-pill-emergency-contraceptive-1486.html. 
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after a federal judge ruled
35
 on the issue, holding that “the agency’s 2006 decision to limit 
availability of the controversial contraception to women 18 and older was invalid and politically 
motivated.”36  While this paper is not concerned with the political and religious undertones of the 
debate over OTC Plan B, these considerations cannot be ignored because they drove the next 
stage in the history of OTC Plan B.  This stage saw results that seemed to disregard scientific 
evidence and to trump politics over considered advice from the medical community.  
The political and implicit religious inclinations regarding whether Plan B should be 
available OTC to all females came to a head in 2011.
37
  At this time, the FDA was ready to 
approve OTC access to Plan B for women and girls of all ages.
38
  In a lengthy statement, FDA 
Commissioner Dr. Margaret Hamburg wrote that the agencies’ scientists “determined that the 
product [Plan B] was safe and effective in adolescent females, that adolescent females 
understood that the product was not for routine use, and that the product would not protect them 
against sexually transmitted disease.”39  But flouting the scientific evidence, and with no 
precedent on the books,
40
 the Department of Health and Human Services secretary, Kathleen 
Sebelius, publicly overruled the FDA’s decision.41  Secretary Sebelius based her decision on 
                                                                                                                                                                                  
34 Rob Stein, 17-Year-Olds Gain Access to Plan B Pill, WASH. POST, Apr. 23, 2009, 
http://www.washingtonpost.com/wp-dyn/content/article/2009/04/22/AR2009042202248.html.  
35 Tummino v. Torti, 603 F. Supp. 2d 519, 524 (E.D.N.Y. 2009) (“Indeed, the record is clear that the FDA’s course 
of conduct regarding Plan B departed in significant ways from the agency’s normal procedures regarding similar 
applications to switch a drug product from prescription to non-prescription use, referred to as a ‘switch application’ 
or an ‘over-the-counter switch.”). 
36 Stein, supra note 34. 
37 See, e.g., Editorial, Politics and the Morning-After Pill, N.Y. TIMES, Dec. 7, 2011, 
http://www.nytimes.com/2011/12/08/opinion/politics-and-the-morning-after-
pill.html?ref=policy&gwh=95631044E0EFEE5D87DD57F1A07DC42C (This editorial states that “once again, the 
politics of birth control have trumped science and sound public policy,” while mentioning that “social and religious 
conservatives have lobbied for years to restrict access to the pill”);  
38 Gardiner Harris, Plan to Widen Availability of Morning-After Pill is Rejected, N.Y. TIMES, Dec. 7, 2011, 
http://www.nytimes.com/2011/12/08/health/policy/sebelius-overrules-fda-on-freer-sale-of-emergency-
contraceptives.html?_r=0&gwh=EB01D02592AC9885A36D38052B5F33BB. 
39 Id. 
40 Though it is legal for the secretary of the Department of Health and Human Services to overrule the FDA. 
41 Id. 
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insufficient data: “the data provided as part of the actual use study and the label comprehension 
study are not sufficient to support making Plan B One-Step available to all girls 16 and younger, 
without talking to a health care professional.”42   
Interestingly, for purposes of this piece, Secretary Sebelius, in noting that approximately 
ten percent of girls at age eleven can become pregnant, mentioned that “there are significant 
cognitive and behavioral differences between older adolescent girls and the youngest girls of 
reproductive age.”43  Perhaps, then, whether or not to place an “age floor” for OTC Plan B, when 
taking into account cognitive decisional capacity, is a legitimate scientific question.  This piece 
will now explore scientific sources regarding an adolescent’s cognitive ability to make medical 
decisions, and the extent to which this cognitive ability should grant such an adolescent the 
power to make autonomous healthcare decisions.  
II. INDIVIDUAL AUTONOMY, MEDICAL DECISIONS, AND ADOLESCENTS’ COGNITIVE ABILITY 
 
 Respect for autonomy is “a central value in Western medicine and medical ethics.”44  But 
pinning down an exact definition of this concept, in any context, is difficult.  Various distinctions 
of terminology exist, including moral autonomy,
45
 personal autonomy,
46
 and basic autonomy.
47
  
Conceptual and philosophical distinctions abound, and are, as expected, extremely complex and 
subject to scholarly debate.  This piece, however, focuses on a distinct version of autonomy: 
autonomy in the bioethical sense, utilized in making personal healthcare decisions.  And it is this 
                                                        
42 Department of Health & Human Services, Statement by Kathleen Sebelius, Dec. 7, 2011, available at 
http://www.hhs.gov/news/press/2011pres/12/20111207a.html. 
43 Id. 
44 Jukka Varelius, The Value of Autonomy in Medical Ethics, 9 MED. HEALTH CARE PHILOS. 3, 3 (2006). 
45 Moral autonomy, in the Kantian sense, is “the capacity to impose the (objective) moral law on oneself, and . . . is 
claimed as a fundamental organizing principle of all morality.” Stanford Encyclopedia of Philosophy, “Autonomy in 
Moral and Political Philosophy,” available at http://plato.stanford.edu/entries/autonomy-moral/#AutRelationalAut. 
46 Personal autonomy “celebrates creative self-authorship and encourages the development of those virtues (such  
as integrity and authenticity) that support it.”  Robert S. Taylor, Kantian Personal Autonomy, 33 POL. THEORY 5, 
602 (2005). 
47 Basic autonomy is “the minimal status of being responsible, independent and able to speak for oneself.” Stanford 
Encyclopedia of Philosophy, “Autonomy in Moral and Political Philosophy,” available at 
http://plato.stanford.edu/entries/autonomy-moral/#AutRelationalAut. 
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sense of autonomy through which this piece analyzes the degree to which adolescents should be 
responsible for their healthcare decisions, specifically, whether to use Plan B. 
 Decisional autonomy in the healthcare realm—a complex and even philosophical issue—
“is predicated on decision-making capacity.”48  In bioethical discourse, autonomy is the principle 
out of which grew the doctrine of informed consent, which, generally, is the process “by which a 
fully informed patient can participate in choices about her health care.”49  People should have a 
say in decisions about their medical care, and as rational actors, must be properly informed by 
their physicians to make such decisions.
50
  From a philosophical perspective, we justify the 
principle of decisional autonomy in medical decisions—and define decision-making capacity—
using different subsets of perhaps elusive variables.  For example, one scholar has said such 
variables include “an ability to understand information, to deliberate about it, and to 
communicate a choice with clarity.”51   
Bioethics scholars trying to provide clarity to the doctrine of informed consent have 
borrowed language from the law’s attempt to define “consent.”52  This includes an individual’s 
ability to give “voluntary, knowing, and intelligent” consent.53  While perhaps never definitive, 
legal and bioethical scholars have tried to pin down definitions of these modifiers.  For example, 
one bioethics scholar has defined “voluntary” as a patient’s ability “to provide consent that is not 
                                                        
48 Rhonda Gay Hartman, Adolescent Decisional Autonomy for Medical Care: Physician Perceptions and Practices, 
8 U. Chi. L. Sch. Roundtable 87, 87 (2001). 
49 Univ. Washington School of Medicine, “Ethics in Medicine: Informed Consent,” available at 
http://depts.washington.edu/bioethx/topics/consent.html. 
50 Id. 
51 Hartman, supra note 48, at 87. 
52 See Thomas Grisso & Linda Vierling, Minors’ Consent to Treatment: a Developmental Perspective, 9 PROF. 
PSYCHOL. 3 (1978). 
53 See, e.g., Brady v. United States, 397 U.S. 742, 748 (1970) (“Waivers of constitutional rights not only must be 
voluntary, but must be knowing, intelligent acts done with sufficient awareness of the relevant circumstances and 
likely consequences”). 
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merely an acquiescent or deferent response to authority.”54  She defined “knowing” as “the 
match between the information given to the patient and the patient’s own paraphrase of that 
information,” and “intelligent” as “the competence of the patient to arrive at the consent decision 
rationally, not upon others’ opinions concerning the advisability of the patient’s decision 
itself.”55  Informed consent, then,  “is a primary means of respecting the autonomy of patients 
because one cannot act autonomously when denied access to information that is pertinent to the 
decision at hand.”56   
The law incorporates bioethical ideas of autonomy, informed consent, and decisional 
capacity in its decree that adults,
57
 but not adolescents,
58
 are presumed capable of making their 
own healthcare decisions.
59
  Thus, the law presumes that adolescents are not capable of making 
their own medical decisions.  This presumption is subject to numerous exceptions, including 
medical care for emergencies, treatment of sexually transmitted diseases, drug or alcohol 
dependency, mental health treatment, and abortion.
60
  These exceptions are grounded in both 
practical and ethical concerns.
61
  The practical concerns include the public health goals of 
preventing the spread of disease, preventing drug abuse, and allowing access to stigmatized 
treatments for which adolescents might fear telling their parents.
62
  The ethical concerns 
highlight the value and benefit that autonomous decision-making brings to individuals.
63
  
Anomalously, the law presumes that adolescents do not possess the cognitive and emotional 
                                                        
54 Kimberly M. Mutcherson, Whose Body is it Anyway? An Updated Model of Healthcare Decision-Making Rights 
for Adolescents, 14 CORNELL J.L. & PUB. POL’Y 251, 284–85 (2005). 
55 Id. 
56 Id. at 294. 
57 Those individuals eighteen years of age—the age of majority—and older. 
58 Generally those ranging from age fourteen to seventeen. 
59 Hartman, supra note 48, at 88. 
60 Id. at 90. 
61 See Mutcherson, supra note 54, at 270. 
62 Id. at 270–72. 
63 Id. at 272–78. 
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maturity to make their own health care decisions—unless the healthcare decisions are for “adult 
problems.”64    
The presumption that adolescents are incapable of making healthcare decisions derived 
from late nineteenth- and early twentieth-century notions of society that have not kept pace with 
developmental psychology.
65
  In fact, vast quantities of medical research suggest that adolescents 
are capable of making autonomous healthcare decisions, at the very least beyond the level 
presently presumed by law.
66
  One study found “little evidence that minors of age fifteen and 
above as a group are any less competent to provide consent [for medical decisions] than are 
adults.”67  Another study showed that as early as age fourteen, minors are as competent as adults 
to make autonomous healthcare decisions.
68
  A study on decision-making during pregnancy 
found that fourteen through seventeen year olds were similar to adults in cognitive ability and 
volition, and “remain competent decision makers when facing an emotionally challenging real 
world decision.”69  In our society—which puts a high value on autonomy and individual 
freedoms—if an adolescent possesses the same level of cognitive ability as an adult, then it 
                                                        
64 For example, a seventeen-year-old can seek STD treatment without parental consent, but would need parental 
consent to treat a complication arising from the STD treatment.  Even more incongruous are the following examples: 
“a teenage mother must give consent before her baby may be treated, but, by and large, is not permitted to consent to 
her own health care.  An adolescent boy can be tested and treated for HIV without parental involvement, but his 
parents must consent to setting his broken leg.”  Michelle Oberman, Minor Rights and Wrongs, 24 J.L. MED. & 
ETHICS 127, 127 (1996). 
65 See Hartman, supra note 48, at 90; see also Bellotti v. Baird, 443 U.S. 622, 638 (1979) (“Deeply rooted in our 
Nation’s history and tradition, is the belief that the parental role implies a substantial measure of authority over 
one’s children.”).   
66 Id. at 96. 
67 Grisso & Vierling, supra note 52, at 423. 
68 Lois A. Weithorn & Susan B. Campbell, The Competency of Children and Adolescents to Make Informed 
Treatment Decisions, 53 Child Dev. 1589, 1595 (1982).  “The age of 18 or 21 as the ‘cutoffs’ below which 
individuals are presumed to be incompetent to make determinations about their own welfare do not reflect 
psychological capacities of most adolescents.”  Id. at 1595–96. 
69 Bruce Ambuel & Julian Rappaport, Developmental Trends in Adolescents’ Psychological and Legal Competence 
to Consent to Abortion, 16 LAW & HUM. BEHAV. 129, 147 (1992). 
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logically follows that she “should play a significant role in determining the course of her medical 
treatment.”70 
Courts have used two main justifications regarding the presumption that adolescents are 
incapable of making autonomous medical decisions: “(1) adolescents are not capable of making 
important life decisions; and (2) courts assume that parents, after being informed by the 
physicians, will make decisions in the best interests of the child.”71  The above discussion 
regarding developmental psychology dispels the first justification.
72
  As for the second 
justification, while (we hope) most parents will make medical and other decisions in the best 
interests of their children, for a variety of reasons,
73
 not all do.
74
  Cases of child abuse aside, “for 
some parents, despite best intentions and grave concern, their instincts may not always serve the 
best interests of a child.”75  This evidence calls for a reexamination of the assumptions 
underlying the jurisprudence of adolescents and their capacity as autonomous decision-makers. 
Presumptive decisional incapacity for adolescents contravenes social norms and trends in 
other areas—these include juvenile delinquency and family court, “where adolescents are 
afforded decisional autonomy and accompanying accountability.”76  In family law, the older a 
child gets, the more say he or she has in matters concerning, for example, custody, visitation 
rights, and adoption.
77
  Tort law provides no immunity based solely upon the age of an accused 
tortfeasor; rather, the tort duty is phrased in language like “how a reasonable fourteen year old 
                                                        
70 Anthony W. Austin, Medical Decisions and Children: How Much Voice Should Children Have in their Medical 
Care?, 49 ARIZ. L. REV. 143, 149 (2007). 
71 Id. at 151–52. 
72 See text accompanying notes 22–27. 
73 For example, some parents might physically and emotionally abuse their children, and then refuse to seek 
treatment for their children to avoid legal and criminal ramifications. 
74 See Mutcherson, supra note 54, at 282. 
75 Id.  For example, a parent might attempt to prevent his child from receiving a life-saving blood transfusion for 
religious reasons.   
76 Hartman, supra note 48, at 89. 
77 Id. 
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(or fifteen or sixteen year old, etc.) would act in a given situation.”78  These examples show the 
exception to the rule: as children develop cognitively and gradually attain decisional maturity, 
they become increasingly able to become more involved in making autonomous decisions and 
otherwise participating in society in general.  But “in choosing the chronological age marker of 
eighteen, the law denies rights to fourteen to seventeen-year-old adolescents who are generally 
capable of exercising such rights in a thoughtful fashion.”79   
Given the increasing cognitive ability and competency of adolescents with each 
successive year, the purported presumptions do not represent reality with respect to 
adolescents.
80
  Adolescents approach medical decisions “with a quality of intentionality that is 
not seen in the decisions made by children,”81 which suggests that recognizing adolescent 
autonomous decision-making for healthcare “may improve their response to treatment and 
encourage the development of self-efficacy.”82  While a few states have recognized the “mature 
minor”83 doctrine, and in the abortion context the Supreme Court allows for “judicial bypass”84 
of the parents’ wishes, the law does not contain the requisite flexibility to deal with adolescent 
decision-making.   
The proposed autonomy analysis of this piece requires one to “‘reject the formulation that 
the adolescent is being protected [and i]nstead . . . view the [traditional] insistence on parental 
                                                        
78 Mutcherson, supra note 54, at 290. 
79 Id. at 254. 
80 See Jessie Hill, Medical Decision Making by and on Behalf of Adolescents: Reconsidering First Principles, 15 J. 
HEALTH CARE L. & POL’Y 37, 39 (2012). 
81 David G. Scherer, The Capacities of Minors to Exercise Voluntariness in Medical Treatment Decisions, 15 LAW 
& HUM. BEHAV. 431, 446 (1991). 
82 Id. 
83 The “mature minor” doctrine “allows minors who can understand the nature and consequences of the medical 
treatment being offered the legal power to consent or refuse treatment in situations in which parental consent would 
be difficult to obtain or would cause family conflict.”  Austin, supra note 70, at 159. 
84 See Baird 443 U.S., at 643–44 (holding that a minor who wished to avoid parental-consent requirements for 
abortion must be given the opportunity to bypass the requirement by proving to a judge that either she is mature 
enough to make the abortion decision on her own, or that abortion would be in her best interests). 
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consent as a denial of the adolescent’s rights as a person, separate from his parents.”85  For those 
who believe that it is sacrilege to put autonomous medical decisions in the hands of minors, all 
autonomous actors, adults and children alike, do not always act rationally, or with compassion, 
or according to everyone’s competing ideals.  In the words of one scholar: 
it is false to suggest that young people lack autonomy because they may make 
decisions that appear irrational, cruel, or otherwise deficient.  Autonomy need not 
rest on an assessment of the decision that might have been made by another, but 
instead is premised upon the process by which an actor reaches a decision.
86
 
 
Thus, when the cognitive ability of an adolescent enables her to reach decisions based on a 
similar process to that of adults, she should be able to make autonomous medical decisions.  This 
does not mean that the adolescent should not have input from her parents or other concerned 
individuals; dependence and an autonomous existence are not mutually exclusive.
87
  For “in the 
continuous development of the relative-adult out of the relative-child there is no point before 
which the child himself has no part in his own shaping, and after which he is the sole responsible 
maker of his own character and life plan.”88 
Thus, this article puts forth the following framework: once reaching the age of fourteen, 
the adolescent, based on her maturity and cognitive development, should be allowed to make 
certain autonomous healthcare decisions.  As the adolescent reaches the age of seventeen she 
should be given more autonomy to make such decisions, again, qualified by her developmental 
ability to make such decisions.  To the extent that the maturity level of an adolescent would 
preclude her from making a completely autonomous medical decision, the parent should decide, 
with the adolescent having substantial input.  Healthcare providers and courts should take this 
                                                        
85 Thomas J. Silber, Ethical Considerations in Caring for Adolescents, 10 PEDIATRIC ANNALS 408, 409 (1981). 
86 Mutcherson, supra note 54, at 277. 
87 Id. at 273. 
88 Joel Feinberg, “Autonomy,” THE INNER CITADEL: ESSAYS ON INDIVIDUAL AUTONOMY 27, 34 (John Christman, 
ed. 1989). 
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input seriously, in the same vein as the family law context mentioned above.  And the law should 
apply this framework for all medical decisions, including the OTC Plan B controversy. 
III. WHY THE INDIVIDUAL AUTONOMY FRAMEWORK SHOULD BE APPLIED TO ADOLESCENTS’ 
DECISIONS REGARDING OTC PLAN B 
 
This article has advocated for the principal of autonomy in medical decision-making.
89
  
When feasible, we should put the ball in the patient’s court to make her own medical decisions, 
based on sound medical advice as well as advice from friends and family.  This framework faces 
the least resistance when a fully capable adult makes the healthcare decision—indeed the law 
presumes that adults over the age of majority have decisional capacity.
90
  But when an 
adolescent, under the age of eighteen, is faced with the same medical decision, the law and 
society in general push back.
91
  In many cases, the law presumes that adolescents do not possess 
the cognitive and emotional maturity to make their own health care decisions.
92
   And the 
societal opposition is especially acute when the medical decision involves reproductive rights
93
 
and reproductive health.
94
  This piece will now argue for the application of the cognitive 
development framework set out in Part II to OTC Plan B specifically, and then advocate the use 
of that approach to solve the Plan B debates. 
A recent New York City pilot program
95
 that provides high school students with Plan B 
and other contraceptives without parental consent has received considerable media attention.
96
  
Interestingly, the pilot program appears to have received very little resistance from the parents of 
                                                        
89 See supra, Part II. 
90 See Hartman, supra note 5, at 88. 
91 Id. 
92 See Oberman, supra note 63, at 127. 
93 For example, the rights to contraception and to abortion. 
94 See Alicia Munday, Election Night with Abortion-Rights and Anti-Abortion Groups, WALL ST. J., Nov. 7, 2012, 
http://blogs.wsj.com/washwire/2012/11/07/election-night-with-abortion-rights-and-anti-abortion-groups. 
95 See Hartocollis, supra note 2.  The program was designed to deal with the fact that “in New York City, over 7,000 
young women become pregnant by age 17 – 90 percent of which are unplanned.”  Its “new approach” was designed 
to “improve a situation that can have lifelong consequences.”  Id.   
96 Id. 
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the adolescents receiving the contraceptives.
97
  In the 2011-2012 school year, 567 young women 
received Plan B emergency contraception from the program, while only 1-2 percent of parents 
chose the “opt-out option,” which would prevent their children from receiving any 
contraceptives through the program.
98
  Given the 180-day school year, that means that an 
average of 3.15 Plan B regiments were distributed to high school students daily.   
Presumably a large number of the adolescents receiving Plan B through the New York 
City public high school pilot program are under age 17, and thus circumvent the current 
requirement that girls under 17 get a prescription before they can receive Plan B.
99
  But, as 
mentioned above, the parents of these adolescents amendable to the program did not opt out.
100
  
Thus, in certain areas of New York City, a vast majority of parents implicitly believe that their 
adolescent daughters can make the decision whether to use Plan B on their own.  Even assuming 
that New York is more progressive toward reproductive rights generally, and might be a 
potential outlier from a national perspective, a key distinction to keep in mind is that the parents 
allowed their children to make their own decision regarding Plan B.
101
   
Perhaps then, in the event that other localities enact programs similar to that in New 
York, the resistance that some people would feel toward such a program would be based on an 
aversion toward birth control, Plan B, or abortion generally, and would have nothing to do with 
questions of decisional autonomy and cognitive development in adolescents.
102
  Also, the 
                                                        
97 Id. 
98 Id. 
99 Id. 
100 Even assuming some of the parents had no idea about the program, which is not likely to have been the case in 
large numbers, the underwhelming 1-2 percent opt-out rate shows a large degree of parental acquiescence to the 
program. 
101 Hartocollis, supra note 2. 
102 We would then have a clash between parents, who do not approve of Plan B for their daughters, and the 
daughters’ individual autonomy in making such a decision.  This article takes the position that autonomous decision-
making should always trump having decisions made for you.  Thus, the parents are free to refrain from using Plan B 
and other contraceptives themselves, but the parents should not be able to prevent their daughters from accessing 
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aversion potentially would have nothing to do with scientific research and sound medicine.  As 
mentioned above, the FDA “determined that the product [Plan B] was safe and effective in 
adolescent females, [and] that adolescent females understood that the product was not for routine 
use.”103  Secretary Sebelius and the Department of Health & Human Services, however, 
disagreed with the FDA and overruled the FDA’s decision to approve OTC Plan B for all 
ages.
104
  Sebelius based this decision on her finding that there was insufficient data to support 
OTC Plan B for adolescents under seventeen.
105
   
The disagreement here between the FDA and the Department of Health & Human 
Services has been criticized as largely, if not completely, political.
106
  Also, the way the 
disagreement has played out among the citizenry is not only political,
 
but often ignores valid 
scientific and medical research, and neglects to take into account decisional capacity with a 
processed-based approach.
107
  In the context of medicine, political inclinations should take a 
                                                                                                                                                                                  
OTC Plan B, assuming the young women possess the cognitive ability to decide for themselves.  The spirit of such a 
conclusion in this piece finds a parallel in this piece’s approach to abortion.  Specifically, that approach stands for 
the idea that one can disapprove of abortion for herself, but cannot force another woman to forego obtaining a legal 
abortion.  In general terms, everyone is free to not take advantage of a positive right for herself, and at the same 
time, no one may force another to not take advantage of that positive right.  The same is true, albeit conversely, for a 
“negative right,” like the right not to believe in a certain religion. 
103 Gardiner Harris, Plan to Widen Availability of Morning-After Pill is Rejected, N.Y. TIMES, Dec. 7, 2011, 
http://www.nytimes.com/2011/12/08/health/policy/sebelius-overrules-fda-on-freer-sale-of-emergency-
contraceptives.html?_r=0&gwh=EB01D02592AC9885A36D38052B5F33BB. 
104 Department of Health & Human Services, Statement by Kathleen Sebelius, Dec. 7, 2011, available at 
http://www.hhs.gov/news/press/2011pres/12/20111207a.html. 
105 Id. 
106 See Harris, supra note 103 (“The decision ensures that Plan B will continue to be far more important as a 
political issue than for public health.”); see also Laura Meckler & Jennifer Corbett Doorren, Obama Backs Plan B 
Move, WALL ST. J., Dec. 9, 2011, available at 
http://online.wsj.com/article/SB10001424052970203413304577086472287736982.html  (“The politics of the 
decision could have cut two ways for Mr. Obama. Had his administration allowed unrestricted sales of the drug, 
critics were sure to attack him from the political right. Some social conservatives view the use of the "morning 
after" drug as akin to abortion, and they were likely to accuse the president of affording young girls the ability to 
end a pregnancy on their own.  But blocking the drug opens him up to criticism from the political left.”).   
107 See Mutcherson, supra note 54, at 277 (advocating for an approach for measuring cognitive ability that prioritizes 
the process by which adolescents make decisions, and not confusing the importance of a processed-based approach 
with a results-based approach whereby decisions are demonized in hindsight). 
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backseat because medicine, at its core, is not a political question, but a scientific one.
108
  Too 
much political bickering on issues that people hold close to heart not only prevents peaceable 
solutions, but also potentially stalls novel approaches to resolve such disputes.  The vitriol 
between the two camps
109
 regarding the right to an abortion, for example, is still going strong 
despite the fact that the Supreme Court definitively ruled to give women such a right almost forty 
years ago.
110
  Rather than facilitate the implementation of the law, or perhaps more 
constructively, to figure out ways to help prevent the need for an abortion, many are content to 
advocate abolishing the right to an abortion.
111
  This is extremely unlikely to happen, in large 
part because the scientific community has essentially come to a consensus on the safety of 
regulated abortions.
112
  
                                                        
108 Doctors and scientists should drive the policy on medicine and healthcare treatments.  How these treatments and 
drugs should be paid for, and other health insurance questions, are beyond the scope of this article and have no 
bearing on this piece’s argument regarding decisional autonomy in the healthcare context.  The thesis can be 
understood as follows: once the medical community puts forth valid medical research supporting a certain treatment, 
here Plan B, an adolescent, assuming she possesses the cognitive ability to appreciate such a decision, should be able 
to decide whether to utilize that treatment.  
109 Pro-choice, those that support a woman’s right to make the abortion decision on her own; and pro-life, those who 
believe that abortion is always morally wrong and should be illegal, with the possible exception of cases of rape or 
incest.  Recent studies, however, are asking “whether these binary, politicized labels accurately capture Americans’ 
nuanced views on abortion,” while pointing out that “support for legal abortion has remained steady even as 
Americans’ identification with the politicized “pro-choice” or “pro-life” labels has fluctuated.”  Robert B. Jones, 
Pro-Choice and Pro-Life? On Abortion, Americans It’s Complicated, WASH. POST, May 29, 2012, available at 
http://www.washingtonpost.com/blogs/figuring-faith/post/pro-choice-and-pro-life-on-abortion-americans-say-its-
complicated/2012/05/29/gJQAjj0qyU_blog.html.  
110 See Roe v. Wade, 410 U.S. 113 (1973) (holding that the right to privacy found in the Due Process Clause of the 
Fourteenth Amendment extended to a woman’s decision to have an abortion). 
111 See Jennifer Steinhauer, Akin Controversy Stirs up Abortion Issues in Campaign, N. Y. TIMES, Aug. 21, 2012, 
http://www.nytimes.com/2012/08/22/us/politics/todd-akin-controversy-may-hurt-republican-
chances.html?pagewanted=all (describing the comments of Missouri Representative Todd Akin, who claimed that 
victims of something he calls “legitimate rape” have a mechanism in their bodies that somehow prevent pregnancy; 
this novel idea was used to combat the so-called “rape exception” found in proposed anti-abortion legislation). 
112 Indeed the only changes in the constitutional jurisprudence on abortion since Roe have revolved around new 
scientific information coming to light, especially regarding viability of a fetus.  See Casey, 505 U.S. 833 (affirmed a 
woman’s right to have an abortion, and incorporated new scientific evidence regarding viability in fashioning a new 
abortion framework). 
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Although debates continue to rage over reproductive health and reproductive rights, 
people usually do not take issue with drugs that become available OTC.
113
  For example, 
ibuprofen, originally a prescription-only NSAID,
114
 was approved by the FDA for OTC use, as 
Advil, in 1984.
115
  Today people take Advil to help relieve pain and headaches without much 
thought.
116
  People feel the pain, want to alleviate it, know Advil works to do so, and then ingest 
the Advil if they decide it is a proper course of action given the circumstances—adults and 
children age 12 and over are directed to take the same dose and are susceptible to the same side 
effects.
117
  And people throughout the world have Advil in medicine cabinets.
118
  It would not be 
remiss to claim that once medical treatment is deemed safe, then society generally believes that 
people should be able to decide for themselves whether to use such a treatment.   
Most people will concede that one may decide for herself whether to take an Advil, 
safeguarded by the fact that the FDA approved that drug for OTC use—an approval process that 
requires a rigorous scientific process.
119
  Further, but for Secretary Sebelius’s political rejection 
of the FDA’s recommendation, Plan B would be available to all adolescent women OTC based 
on sound scientific evidence.
120
  Yet, even though those FDA safeguards are present in the Plan 
B “OTC switch,” large swaths of American society might cringe at the idea of a minor deciding 
for herself whether to use Plan B.  And it is this “cringing,” and its accompanying backlash, that 
                                                        
113 In fact, consumers generally benefit from OTC drugs because once drugs are OTC, they foster competition, 
which drives down prices.  Harlan Levine, Room for Debate: Getting your Prescription without a Prescription - Let 
Competition Cut Costs, N. Y. TIMES, Sept. 12, 2012, http://www.nytimes.com/roomfordebate/2012/09/16/getting-
your-prescriptions-without-a-prescription/consumers-benefit-from-over-the-counter-competition. 
114 Non-steroidal anti-inflammatory drug. 
115 See Advil, FAQs, available at http://www.advil.com/faqs. 
116 Although some people object to taking these types of drugs, and any drugs, for religious and other reasons. 
117 See Advil, FAQs, available at http://www.advil.com/faqs (side effects include ulcers, if the medicine is not taken 
properly). 
118 See The Branding Blog, The Law of Leadership, BRANDING STRATEGY INSIDER, Apr. 11, 2009, 
http://www.brandingstrategyinsider.com/2009/04/the-law-of-leadership.html (Advil has 51 percent of global market 
share for ibuprofen). 
119 See FDA, “Development & Approval Process (Drugs),” available at 
http://www.fda.gov/drugs/developmentapprovalprocess/default.htm. 
120 Harris, supra note 38. 
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call for the application of the decisional autonomy framework from Part II to the OTC Plan B 
controversy.  
Decisional autonomy on personal and sensitive healthcare decisions like abortion and 
Plan B, which have been sanctioned by medical science, should be the fundamental principle 
grounding any policy discussions thereon.  Once a treatment is deemed safe, the person seeking 
such treatment should be able to decide for herself whether to take advantage of such a 
treatment, regardless of her age.  If a woman’s personal values caution her against the use of 
Plan B, and she elects not to use Plan B in a relevant situation, then decisional autonomy has 
won the day, and the integrity of that individual remains intact.  But when that same woman 
cannot decide on her own—either because someone forced her to take Plan B or because 
someone prevented her from taking Plan B—then the woman has lost the ability to control her 
own life, and perhaps has lost a bit of herself.  For these reasons, and for those discussed in Part 
II and in this part, above, adolescents who possess the cognitive ability to make healthcare 
decisions should decide for themselves whether to use Plan B.  This application of the principle 
of autonomy in medical decision-making calls for Plan B to be available to all decisionally 
capable adolescents, regardless of age.  The next section of this piece will use the 
aforementioned framework to put forth a solution to the OTC Plan B debate, and will open up its 
analysis to include a broader policy discussion. 
IV. A SOLUTION TO THE DEBATE REGARDING OTC PLAN B FOR ADOLESCENT WOMEN 
 This article has argued that Plan B, approved for OTC use by seventeen-year-old women, 
should also be approved for OTC use by all adolescent women who possess the cognitive ability 
to make autonomous decisions.  In the case of Plan B, the scientific and medical research shows 
two crucial factors: (1) Plan B is safe; and (2) adolescents younger than seventeen understand 
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and appreciate the decision-making process to take Plan B.
121
  After balancing public health 
against individual liberty, and because their decision-making faculties and the literature on Plan 
B’s safety dictate that their decisional autonomy should be respected, these adolescents should 
decide whether to take Plan B for themselves whenever possible.   
This Part of the article first focuses on the rights of parents versus the rights of their 
children to choose to use Plan B.  It concludes that, based on the principles of decisional 
autonomy and cognitive ability, in the case of Plan B, the rights of the adolescent trump those of 
the parents.  Part IV-B then discusses some comparative cases of age-based regulation, including 
the right to buy and use tobacco products and the contractual doctrine of minority incapacity.  
This article hopes to use the similarities and differences between these other age-based 
regulations and the OTC Plan B debate to both bolster its central thesis and to suggest that age-
based regulations are oversimplifications of more complex issues.  This section will then open up 
its central thesis to address broader considerations and suggest how the principles of decisional 
autonomy and cognitive ability can be a better approach than purely age-based regulations in 
various areas. 
A. Dealing with the Purported Rights of Parents 
 Two long-standing presumptions have influenced the jurisprudence surrounding the 
balancing of interests between parents and their minor children regarding medical decision-
making.
122
  The first presumption is that, unless an exception applies,
123
 “minors lack the legal 
authority to consent to medical treatment on their own.”124  The second presumption holds that 
                                                        
121 See supra, Part I. 
122 See Hill, supra note 80, at 38 (The thesis of Hill’s article is to question these two presumptions and show that 
after reconsidering them, the law should give more discretion to minors, especially adolescents, in making medical 
decisions). 
123 See Part II, supra, text accompanying notes 56-60. 
124 Hill, supra note 80, at 38. 
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“parents have a legal entitlement to make medical decisions for the minor child.”125  The validity 
of these presumptions are legally true, as they undergird much of the positive law in the United 
States surrounding healthcare decisions for and by minors.
126
  But the medical research 
mentioned above
127
 shows that, with adolescents, the validity of these presumptions in practice 
is questionable at best.  Furthermore, there is a sort of cognitive dissonance with how the rights 
of the parent versus the rights of the child play out in this area.
128
 
 The constitutional rights of the parents and those of the adolescent regarding medical 
decision-making, especially in the reproductive rights context, are in conflict.  Parents possess 
the right to direct the upbringing of their children, free from state interference.
129
  Yet 
adolescents also possess a constitutional right to bodily integrity.
130
 Professor Anne Dailey 
eloquently lays out the crux of the dilemma regarding the balance of the rights of the child 
against those of the parent: 
Any allotment of liberty to the parents necessarily diminishes the liberty of the 
child; conversely, any enhancement of the child’s liberty curtails that of the 
parents.  Unlike the right of individual privacy—which entitles the individual to 
rights against the state and over herself—parental rights entitle parents to rights 
against the state, but over another person.
131
 
 
In keeping with the principle of autonomy and the framework of respecting adolescents’ 
cognitive ability to make healthcare decisions, the adolescent’s right to bodily integrity should 
                                                        
125 Id.   
126 Id. at 39–40. 
127 See Part II, supra (citing numerous studies regarding the cognitive ability of adolescents to make their own 
medical decisions). 
128 Hill, supra note 80, at 56. 
129 See Pierce v. Soc’y of Sisters, 269 U.S. 510 (1925) (parents have a constitutional right to raise their children 
without state interference). 
130 See Planned Parenthood v. Danforth, 428 U.S. 52 (1976) (states cannot give a parent an absolute veto over a 
minor’s decision to have an abortion); see also Baird, 443 U.S. at 643 (judicial bypass procedures allowing minor to 
circumvent parental consent regarding abortion decisions). 
131 Anne C. Dailey, Constitutional Privacy and the Just Family, 67 TUL. L. REV. 955, 986–87 (1993) (cited in Hill, 
supra note 80, at 62–63). 
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outweigh the paternalistic rights of parents whenever feasible.  This is feasible whenever 
adolescents possess the maturity and cognitive ability, from a process-based approach, to make 
their own medical decisions.
132
  Looking toward the future, our laws, especially those 
surrounding such personal decisions as whether to take OTC Plan B, should incorporate these 
policies. 
Refusing to provide Plan B OTC to adolescents under the age of seventeen is implicitly 
letting the parent’s interest outweigh that of the adolescent.133  This not only goes against the 
constitutional arguments for bodily integrity of adolescents—it also ignores recent developments 
in scientific research regarding an adolescent’s cognitive ability to make autonomous healthcare 
decisions.
134
  We should prioritize the bioethical principle of autonomy as much as possible, 
especially when dealing with the decision to utilize safe medical treatments like Plan B.
135
  
Furthermore, the fact that the FDA approved Plan B for OTC use by seventeen-year-olds shows 
that the FDA believes Plan B to be safe for that demographic, as well as that people of that age 
group are able to appropriately decide whether to utilize that treatment.
136
 
Yet Plan B is only available OTC for women 17 and older.  Besides de-prioritizing the 
principle of autonomy, this policy also undermines confidentiality in the medical context, 
another critical element of how people approach healthcare.
137
  Indeed, adolescents are often 
“reluctant to seek certain types of medical treatment if their parents have access to information 
                                                        
132 See Part II, supra. 
133 It would be quite difficult, if not impossible, for teens aged 14-16 to go to a doctor and get a prescription for Plan 
B without their parents finding out, and then preventing the acquisition of the Plan B treatment.  And this is without 
regard to the time constraints surrounding the ineffectiveness of Plan B after seventy-two hours. 
134 See Part II, supra. 
135 See Scherer, supra note 81, at 446 (this is especially true when people, including adolescents, possess the 
cognitive ability to make their own healthcare decisions).  
136 See Kohkjohn, supra note 15, at 375 (generally, an “OTC switch” would not occur but for those conditions being 
in place; also, the FDA’s scientists concluded that Plan B was safe and effective for females of all ages). 
137 See Melissa Prober, Please Don’t Tell My Parents: The Validity of School Policies Mandating Parental 
Notification of a Student’s Pregnancy, 71 BROOK. L. REV. 557, 574 (2005) (describing the importance of 
confidentiality in healthcare, specifically, in building trust between patients and doctors, and between patients and 
the healthcare system as a whole). 
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about their medical treatment.”138  These types of treatment include abortion, contraception, Plan 
B, and other treatments of a delicate and deeply personal nature.
139
   
Ultimately, the young woman facing the need to use Plan B is in the best position to 
decide whether to disclose that fact to her parents.  If she wants to inform her parents and ask for 
help, that is her prerogative, and she is free to do so.  The problem is that the adolescent under 
age 17 does not have the power to make such a decision, in practice.
140
  Adolescents should not 
have to fear making otherwise legal decisions because those decisions must be channeled 
through a parent, who might subject the adolescent to unnecessary contempt, social stigma, or 
punishment.  Plan B is safe and effective, and adolescents possess the cognitive ability to utilize 
a rational decision-making process regarding Plan B.
141
  Thus, any argument here that the 
“parent knows best” fails, and Plan B should be approved OTC for all those adolescents that 
possess the cognitive ability to choose whether to take Plan B.  Comparative examples in other 
contexts can serve to bolster this analysis and its conclusion.  
B. Comparative Cases: Smoking and Contracting 
 America places high value on individual rights and autonomous decision-making, with 
the aim of protecting the people from government intrusion.
142
  Therefore, any regulation, or 
“any interference with liberty, is presumptively invalid and must be justified.”143  Such 
justifications, from the purview of ethics, almost always rely on one of two ideas: (1) the harm 
                                                        
138 Id. at 574–75. 
139 Id. 
140 Again, this is because those 16 and under would need to get a prescription for Plan B before buying it from a 
pharmacy.  It is hard to imagine a scenario where the parent would not either have to be informed about this, or 
would not find out. 
141 See Harris, supra note 38 (quoting FDA Commissioner Dr. Hamburg, who reported that FDA scientists found 
Plan B to be safe and effective in adolescent females, and that they understood that Plan B was not intended for 
routine use). 
142 Thaddues Mason Pope, Balancing Public Health against Individual Liberty: The Ethics of Smoking Regulations, 
61 U. PITT. L. REV. 419, 426 (2000). 
143 Id. at 427.  Depending on the type of regulation, the Constitution demands various levels of scrutiny of 
regulation, ranging from rational basis to strict scrutiny, where the regulation must be narrowly tailored to serve a 
specific government purpose.  This constitutional analysis is being the scope of this paper. 
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principle
144
; and (2) some type of paternalism.
145
  While both of these theories influence laws 
pertaining to adolescents, the driving force justifying such laws is paternalism.
146
  But the 
cognitive development framework espoused by this paper questions such an assumption, and 
would actually assert that the “harm principle” is a better rationalization than paternalism for 
laws treating adolescents different from adults.
147
  Two examples of rules that effect adolescents, 
and are instructive for the OTC Plan B debates, are the tobacco ban for minors and the 
presumption that they lack the capacity to enter contracts.  This piece will now examine the 
justifications behind such laws, and suggest that how they shed light on the OTC Plan B issue. 
i. Smoking 
The laws banning tobacco sales to, and advertising geared toward, minors are almost 
always justified using a paternalistic framework.
148
  The framework is as follows: eye-opening 
statistics of tobacco-related illness and death are followed by an explanation of the addictive 
qualities of nicotine; then come statistics that claim the majority of people have their first 
cigarette under age eighteen, followed by the conclusion that preventing tobacco use among 
adolescents is critical.
149
  Underlying that framework is the belief that people ages sixteen and 
seventeen are somehow more susceptible to tobacco advertising, as well as more likely to not 
understand the consequences of smoking, than those who are eighteen or nineteen years old.
150
  
                                                        
144 This idea originated with John Stuart Mill, who wrote “that the only purpose for which power can be rightfully 
exercised over any member of a civilized community, against his will, is to prevent harm to others.”  John Stuart 
Mill, ON LIBERTY 63 (Penguin ed., 1974).  It has become the “primary philosophical, political, and legal rationale 
for interfering with individual autonomy.”  Pope, supra note 142, at 435. 
145 See Pope, supra note 142, at 429.  “Soft” paternalism justifies intervention where one has assumed risk with 
information asymmetries, or while lacking maturity (i.e. minors), or where coercion exists.  “Hard” paternalism 
“constrains individuals’ decisions even though those decisions are informed and voluntary.”  Id. at 430. 
146 Id. 
147 See Part II, supra. 
148 See Matthew R. Herington, Tobacco Regulation in the United States: New Opportunities and Challenges, 23 NO. 
1 HEALTH LAW 13, 13 (2010) (laying out the framework of tobacco regulation generally, and of youth-related 
tobacco regulation). 
149 Id. 
150 Id. 
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Indeed in the most recent wide-sweeping piece of federal tobacco legislation,
151
 a primary 
justification was that “past efforts to restrict advertising and marketing of tobacco products have 
failed to adequately curb tobacco use by adolescents.”152 
 The “harm principle” –based justifications, and all of smoking’s negative externalities, 
are only strongly put forward when the smoking laws at issue affect “adults”—implicitly, and 
naïvely, non-adults apparently cannot smoke because they cannot buy tobacco products.
153
  For 
example, the harm principle is the primary justification for smoking bans in public places such as 
offices, restaurants, and libraries, with the emphasis on the dangers of “second-hand smoke” and 
smoking mortality rates.
154
  And the negative externalities associated with smoking—added 
shared costs in the healthcare system, reduced productivity in the workplace—also comport with 
the utilitarian idea of the harm principle.
155
  Yet somehow these “adult” concerns are presented 
as only tangentially related to the need to prevent adolescents from beginning to smoke.
156
   
This leaves us in a position where sixteen and seventeen year olds are supposed to be 
banned from smoking because they do not know any better, and where the rights of 
knowledgeable eighteen and nineteen year olds to smoke can be curtailed a bit because smoking 
causes illness and death, and raises social costs.  The arbitrary line-drawing in the tobacco 
context is further baffling when considering that “on average 443,000 people in the United States 
die prematurely each year from exposure to cigarette smoke.”157  Illness and death from smoking 
                                                        
151 Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, § 2, 123 STAT. 1776 (2009). 
152 Id (emphasis added). 
153 Pope supra note 142, at 441. 
154 Id. 
155 Id. at 435. 
156 Id. 
157 Herington, supra note 148, at 13. 
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do not discriminate based on age—whether you start smoking at fifteen or at thirty, you become 
susceptible to all of the negative health consequences associated with tobacco use.
158
  
Just as in the healthcare decision-making context and in the law generally, there is a 
presumption that adolescents are incapable of making behavioral decisions regarding smoking.
159
  
As mentioned above, these presumptions do not comport with current developmental 
psychology, because adolescents as young as fourteen have the same process-based decisional 
capacity as adults.
160
  With smoking, the balancing of individual autonomy against public health 
is essentially: someone eighteen and older can choose to smoke, and assumes the risk, but must 
do so in a private place, so as not to injure non-smokers; but no one under eighteen may smoke, 
because they do not understand the risk.   
With Plan B, we can try to do a similar balancing of individual autonomy against public 
health, but we have to remove the notion of “risk” because medical research has deemed OTC 
Plan B safe for females of all ages.
161
  Plan B also does not pose a threat of injury to others.
162
  
The only sound reason offered for why those under seventeen should not have OTC access to 
Plan B that is not overtly political or religious, is an alleged lack of adequate data supporting its 
safety for that demographic.
163
  Thus, someone seventeen and older can choose to get Plan B 
OTC; but no one under seventeen may do so, because there is a lack of data, although the FDA 
disagrees, and claims that the data is sound.  But as long as that data, insufficient or otherwise, is 
out there, and adolescents possess the cognitive ability to make their own healthcare decisions, 
                                                        
158 Id. 
159 See Hartman, supra note 48, at 90. 
160 See Weithorn & Campbell, supra note 68, at 1595–96 (age 18 as a “cutoff” does not reflect the cognitive and 
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161 Harris, supra note 38. 
162 This paper will not engage in the philosophical ruminations of when life begins.  It does assert, however, that 
Plan B is not an abortifacient.  See Chavlier, supra note 13, at 240. 
163 See Statement by Kathleen Sebelius, supra note 42; see also Editorial, Politics and the Morning After Pill, supra 
note 37 (“once again, the politics of birth control have trumped science and sound public policy”). 
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which they do, adolescents can use that data to make their own decision regarding OTC Plan B.  
And the line-drawing between the ages of seventeen and sixteen is purely arbitrary in the Plan B 
context, just as it is with the presumption that all minors do not possess the capacity to contract. 
ii. Contracting 
 Throughout the history of Anglo-American jurisprudence, all minors have long been 
regarded as lacking the capacity to contract.
164
  One eighteenth-century English judge 
proclaimed that “miserable must the condition of minors be; excluded from the society and 
commerce of the world.”165  The consequence of this bright-line rule is that the contracts of 
minors are voidable, by the minors only, for a reasonable time after they reach the age of 
eighteen, subject to some exceptions.
166
  These exceptions, codified in state laws, include 
contracts for items that are life necessities, contracts for insurance, and contracts for student 
loans, among others.
167
  The justification behind the legal assumption of incapacity for minors to 
contract is that minors “lack the ability to understand and appreciate the consequences of their 
acts,” and are susceptible to overreaching and undue influence by adults.168  This doctrine has 
often been framed in language comparing minors “to those laboring under mental incapacity,” 
but unlike the truly mentally incapacitated, the veil of incapacity is thrown from an adolescent’s 
face the moment she turns eighteen.
169
  This leads to situations where adolescents are licensed to 
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drive by the state, but they cannot purchase a car on their own; and if an adolescent did buy a car, 
she could void that purchase agreement even after she turned eighteen.
170
 
The problem is that any attempt to determine whether a particular minor, even a 
seventeen year old, is competent to contract is conspicuously lacking with this longstanding 
bright-line rule.
171
  This is true even though recent research in developmental psychology 
regarding the decision-making ability of adolescents pokes large holes in the minority incapacity 
doctrine, making it look more and more like historical anachronism.
172
  As one scholar put it, 
“noticeably absent from the scheme governing rights and obligations of minors in the contract 
arena is a recognition of the developmental transition between childhood and adulthood 
commonly referred to as adolescence.”173  It is in the recognition of this transition where the 
principle of decisional autonomy for adolescents, bound by their cognitive ability, has the 
greatest chance to impact these problems in our legal system, by providing a more nuanced 
solution. 
The common law of contracts, as well as the OTC Plan B debates, present a scenario 
where “the threshold capacity issue is either overlooked entirely, or the pendulum of incapacity 
capriciously swings to capacity without examination and explication.”174  Indeed in all areas of 
the law surrounding adolescence, “incongruity reigns supreme” and the discordant approach is 
confusing and bordering irrational.
175
  Our lawmakers need to realize this and utilize what 
developmental psychology and other scientific research tell us about adolescents—that their 
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process-based decisional capacity is no different than that of “adults.”176  Respecting the 
decisional autonomy of adolescents, who possess the cognitive ability to make decisions whether 
to enter into certain contracts and to use Plan B, is a real solution.  This approach is empirical, 
rational, nuanced, and subject to modification based on new information—in other words, it is 
scientific.  It ignores political and religious considerations, especially in the case of reproductive 
rights, which quickly devolve into a quagmire of bickering.
177
  And taking a more empirical and 
scientific approach to our lawmaking generally is also good public policy. 
C. Broader Considerations 
This piece’s conclusions regarding the Plan B debate can offer broader instruction—in 
our policy-making and legislation we must defer more to the medical community and to the 
decisional autonomy of individuals.  It is especially important in the context of the laws 
governing adolescents, which need a complete overhaul because of “the lack of evidentiary 
foundation to sustain presumptive decisional inability” for adolescents.178  The law also treats 
adolescents very inconsistently, and justifies these laws and their various exceptions in different 
ways, and comes close to incoherence.
179
  One scholar has argued: “autonomous decisional 
ability should be the cornerstone for a coherent legal model governing issues of adolescence.”180  
This piece agrees with this notion, and holds that this legal model is especially crucial for the 
OTC Plan B issue, and for reproductive rights issues generally. 
With complex medical issues that implicate bioethical examination, we should try to use 
reason, logic, empiricism, and scientific evidence in crafting legislation.  Too often, this 
methodology becomes co-opted by the political process, which itself often devolves into a 
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partisan screaming match.  This political pandering frequently incites visceral and emotional 
responses, especially at the fringes of both sides of the political spectrum.  And while we want a 
robust debate in the “marketplace of ideas,” too often this debate becomes “white noise” and 
chills any rational and peaceable solution.  Thus, the framework that this piece puts forth to solve 
the OTC Plan B debate, a debate which is heavily politicized and painted with religious and 
moral strokes, can be applied to other hot button issues subject to rigorous and invective debate.  
Deferring to decisional autonomy and to the scientific method, when applicable, will allow 
American society and American legislators to come to the best solutions for the various difficult 
problems that we face on a daily basis.   
CONCLUSION  
 From the principle of individual autonomy in making medical decisions, this article’s 
central thesis is that most adolescent women possess the cognitive and decision-making skills 
necessary to decide whether to use Plan B.  This piece has argued that Plan B, approved for OTC 
use by seventeen-year-old women, should also be approved for OTC use by all adolescent 
women of reproductive age who possess the cognitive ability to make the autonomous decision 
to take Plan B.  The adolescents should decide for themselves whether to take Plan B because 
their decision-making faculties and the literature on Plan B’s safety dictate that their decisional 
autonomy should be respected above all other considerations.  In cases involving reproductive 
rights, and in general, our policy-making and legislation must defer more to the medical 
community and to the decisional autonomy of the individual to make medical decisions.   
The introduction to this piece outlined the political and religious debates surrounding the 
OTC Plan B for adolescents issue.  While reasonable minds can disagree on a final solution to 
this issue, the fact remains that the two sides are arguing about the rights of a third party that 
 30 
does not have any say in the matter.  It is for precisely this reason that individual autonomy, 
wherever possible, should take primacy in our policymaking.  
 
